Akari Therapeutics (AKTX) vs Marker Therapeutics (MRKR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Marker Therapeutics (MRKR) has outperformed Akari Therapeutics (AKTX) over the past year, losing 1.9% versus a loss of 79.5%. Over five years, MRKR leads with a -93.5% price change compared with -99.3% for AKTX. Akari Therapeutics is the larger company by market cap ($19.2 million vs $16.4 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AKTX | MRKR |
|---|---|---|
| Share price | $8.42 | $0.9851 |
| Market cap | $19.24M | $16.42M |
| 1-day change | -2.38% | -5.23% |
| YTD return | -25.39% | -30.20% |
| 1-year return | -79.46% | -1.89% |
| 5-year return | -99.35% | -93.46% |
| EPS (TTM) | $0.00 | $-0.42 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $42.80 | $2.46 |
| 52-week low | $3.02 | $0.84 |
| Distance from 52-week high | -80.33% | -59.96% |
| Average volume | 60.35K | 64.80K |
| Shares outstanding | 2.29M | 16.67M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MRKR has outperformed AKTX by 77.6 percentage points over the past year.
AKTX vs MRKR FAQ
Which is bigger, Akari Therapeutics or Marker Therapeutics?
Akari Therapeutics (AKTX) is larger, with a market capitalization of $19.24M compared with $16.42M for Marker Therapeutics (MRKR).
Which stock has performed better over the past year, AKTX or MRKR?
MRKR returned -1.89% over the past 12 months, compared with -79.46% for AKTX (price return, excluding dividends). Past performance does not predict future results.
Are Akari Therapeutics and Marker Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.